Accuray Incorporated (LON:0H8I)

Market Cap	102.30M
Revenue (ttm)	360.10M
Net Income (ttm)	520.90K
Shares Out	n/a
EPS (ttm)	0.01
PE Ratio	196.38
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	2,679
Average Volume	7,417
Open	1.360
Previous Close	1.380
Day's Range	1.341 - 1.360
52-Week Range	1.145 - 2.940
Beta	n/a
RSI	46.23
Earnings Date	Aug 11, 2025

About Accuray

Accuray Incorporated designs, develops, manufactures, and sells radiosurgery and radiation therapy systems for the treatment of tumors in the United States, Canada, Latin America, Asia, Australia, New Zealand, Europe, the Middle East, India, Africa, Japan, and China. It offers the CyberKnife platform, a robotic stereotactic radiosurgery and stereotactic body radiation therapy system used for the treatment of primary and metastatic tumors outside the brain, including tumors on or near the spine and in the breast, kidney, liver, lung, pancreas, a...

• Industry: Medical - Equipment & Services
• Sector: Healthcare
• Founded: 1990
• Employees: 987
• Stock Exchange: London Stock Exchange
• Ticker Symbol: 0H8I

Financial Performance

In 2024, Accuray's revenue was $446.55 million, a decrease of -0.24% compared to the previous year's $447.61 million. Losses were -$15.55 million, 67.5% more than in 2023.

Financial numbers in USD